Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats

OBJECTIVES: Endothelial dysfunction precedes atherogenesis and clinical complications in type 2 diabetes. The vascular dysfunction in Zucker diabetic fatty (ZDF) rats was evaluated at different ages along with the effect of treatment with rosiglitazone (Rosi) on endothelial function and mechanical r...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Xiao, Guo, Xiaomei, Karathanasis, Sotirios K, Zimmerman, Karen M, Onyia, Jude E, Peterson, Richard G, Kassab, Ghassan S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Original investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891691/
https://www.ncbi.nlm.nih.gov/pubmed/20482873
http://dx.doi.org/10.1186/1475-2840-9-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891691/
https://www.ncbi.nlm.nih.gov/pubmed/20482873
http://dx.doi.org/10.1186/1475-2840-9-19

Ejemplares similares